Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder

200674 citationsJournal Article

Authors

Good health and well-being

Published in: European Child & Adolescent Psychiatry

Volume 15, Issue 2, pp. 105-110

Field-Weighted Citation Impact: 3.73